HalioDx is an immuno-oncology diagnostic company providing oncologists with immune-based diagnostic products and services. Its technology integrates immunohistochemistry combined with advanced imaging analysis enabling extraction of spatially-organized tissue molecular information. The company develops a platform for cancers, as an immune response to the tumor is a key hallmark of disease progression.
|Employees (est.) (Feb 2020)||150|
HalioDx total Funding
HalioDx latest funding size
Time since last funding
|2 years ago|
|Quest for Growth, BNP Paribas Développement, MI Care, Sham Innovation Santé, Sofipaca, PSIM fund|
HalioDx has 932 Twitter Followers. The number of followers has increased 2.2% month over month and increased 5.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was HalioDx founded?
HalioDx was founded in 2014.
Who are HalioDx key executives?
HalioDx's key executives are Vincent Fert, Corinne Danan and Stéphane Debono.
How many employees does HalioDx have?
HalioDx has 150 employees.
Who are HalioDx competitors?
Competitors of HalioDx include FenoMark Diagnostics, Phoenix Molecular Designs and Arquer Diagnostics.
Where is HalioDx headquarters?
HalioDx headquarters is located at 163 Avenue de Luminy, Marseille.
Where are HalioDx offices?
HalioDx has offices in Marseille and Richmond.
How many offices does HalioDx have?
HalioDx has 2 offices.
Receive alerts for 300+ data fields across thousands of companies